Zai Birea*
Non-Small Cell Lung Cancer (NSCLC) is a leading cause of cancer-related deaths worldwide. Recent advancements in the diagnosis and treatment of NSCLC have brought about a paradigm shift in the management of this disease. This article discusses the latest developments in the early detection, diagnosis and treatment of NSCLC. We explore the role of precision medicine, immunotherapy, targeted therapies and innovative diagnostic tools in improving patient outcomes. By understanding these advancements, we can appreciate the progress made in the battle against NSCLC and the hope they bring to patients and healthcare professionals alike.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 